Intravascular flow modifier and reinforcement device and deployment system for same

• US 8,398,700 B2
• Filed: 08/13/2007
• Issued: 03/19/2013
• Est. Priority Date: 02/14/2003
• Status: Expired due to Fees

• Current Assignee: DePuy Synthes Products LLC (Johnson & Johnson)
• Original Assignee: Micrus Corporation (Johnson & Johnson)
• Inventors: Leopold, Eric W., Friedmann, Josef L., Padilla, Neal H.
• Primary Examiner(s): Houston, Elizabeth
• Application Number:
  US11/838,149
• Publication Number:
  US 20080021535A1
• Time in Patent Office: 2,045 Days
• Field of Search: 623 111- 113, 623/1.15, 623 118- 12, 623/1.22, 623/1.3, 623/1.32
• US Class Current: 623/1.12
• CPC Class Codes: A61F 2/88 the wire-like elements formed as helical or spiral coils forming a net-like or mesh-like structure A61F2/90
• CPC Class Codes: A61F 2/89 the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
• CPC Class Codes: A61F 2/95 Instruments specially adapted for placement or removal of stents or stent-grafts
• CPC Class Codes: A61F 2220/0016 with sharp anchoring protrusions, e.g. barbs, pins, spikes

Abstract

A stent includes a cylindrical frame consisting of a series of helical winds containing a pattern of alternating zigzag bends. The frame may be made of resilient wire or from a piece of laser cut hypo tubing by placing the stent over a notched portion of a pusher catheter member, and retained on the pusher catheter member by a release wire threaded through the pusher catheter member and over the stent. The stent may also be deployed by placing the stent over a pusher catheter member having opposing notched portions, and retaining the stent and pusher catheter member in a delivery catheter, which can be withdrawn when stent reaches the site to be treated to release the stent.

Claims

1. A system for deploying an intravascular flow modifier and reinforcement device for use in the intravascular treatment of a target site in a patient'"'"'s vasculature, the system comprising:

an intravascular flow modifier and reinforcement device including a generally cylindrical frame formed of an elongate resilient wire configured as a series of a plurality of helical windings;

a substantially tubular pusher catheter member having an inner lumen, a proximal portion, a distal portion, a tubular main shaft, and a notched portion including a plurality of alternating notches and tubular shoulder portions formed in a side of the pusher catheter member, each of said notches receiving a plurality of the plurality of helical windings; and

a release wire removably threaded through the lumen of the pusher catheter member under said shoulder portions and over said plurality of the plurality of helical windings to retain the plurality of helical windings on said notched portion of said pusher catheter member, said release wire being capable of being withdrawn from said notched portion of said pusher catheter member when the intravascular flow modifier and reinforcement device is positioned at the site in the patient'"'"'s vasculature to be treated to release and deploy the intravascular flow modifier and reinforcement device at the site in the patient'"'"'s vasculature to be treated.

2. The system of claim 1, wherein said release wire is formed of a nickel-titanium alloy.

3. The system of claim 1, wherein said generally cylindrical frame consists of a single elongate resilient wire configured as a series of a plurality of helical windings, each of said helical windings including a series of between 4 and 8 alternating zigzag bends in a rotation of the wire, said generally cylindrical frame having a longitudinal axis, a deployed configuration and a predeployed compressed configuration for placement of the intravascular flow modifier and reinforcement device at the target site, said generally cylindrical frame in its deployed configuration having a helical pattern of sharp alternating zigzag bends aligned to have a chevron configuration when viewed from a first direction transverse to the longitudinal axis, and a reverse chevron configuration when viewed from a second direction transverse to the longitudinal axis.

4. The system of claim 3, wherein said deployed configuration comprises a generally cylindrical configuration.

5. The system of claim 3, wherein said predeployed compressed configuration comprises a radially compressed configuration.

6. The system of claim 3, wherein said alternating zigzag bends have an angle that is less than about 120°

to promote laminar arterial flow.

7. The system of claim 3, wherein said helical windings have a variable pitch.

8. The system of claim 3, wherein each of said helical windings comprises a series of 4 alternating zigzag bends in a rotation of the wire.

9. The system of claim 3, wherein each of said helical windings comprises a series of 6 alternating zigzag bends in a rotation of the wire.

10. The system of claim 3, wherein said elongate resilient wire is formed of a superelastic material.

11. The system of claim 3, wherein said elongate resilient wire is formed of a shape memory material.

12. The system of claim 3, wherein said elongate resilient wire is formed of a nickel-titanium alloy.

13. The system of claim 3, wherein said elongate resilient wire is coated with a corrosion resistant material.

14. The system of claim 3, wherein said elongate resilient wire is coated with parylene.

15. The system of claim 3, wherein said elongate resilient wire is treated by chemical electropolishing to maximize corrosion resistance.

16. The system of claim 3, wherein said elongate resilient wire comprises a stranded cable including one or more radiopaque strands.

17. The system of claim 3, wherein said elongate resilient wire comprises a stranded cable having radiopaque markers deployed along the said stranded cable.

18. The system of claim 17, wherein said stranded cable is made of a material selected from the group consisting of stainless steel, shape-memory alloy, superelastic alloy, platinum and combinations thereof.

19. The system of claim 3, wherein said elongate resilient wire is formed by laser cutting a piece of tubing.

20. A system for deploying an intravascular flow modifier and reinforcement device for use in the intravascular treatment of a target site in a patient'"'"'s vasculature, the system comprising:

an intravascular flow modifier and reinforcement device including a generally cylindrical frame formed of an elongate resilient wire configured as a series of a plurality of helical windings;

a substantially tubular pusher catheter member having an inner lumen, a proximal portion, a distal portion, a tubular main shaft, and a notched portion including at least five alternating notches and tubular shoulder portions formed in a side of the pusher

catheter member, each of said notches receiving more than one of the plurality of helical windings;

a delivery catheter, and wherein said substantially tubular pusher catheter member and the intravascular flow modifier and reinforcement device received on said notched portion of said pusher catheter member are disposed in the delivery catheter, and wherein said delivery catheter can be withdrawn along with said release wire from said notched portion of said pusher catheter member when the intravascular flow modifier and reinforcement device is positioned at the site in the patient'"'"'s vasculature to be treated for delivery of the intravascular flow modifier and reinforcement device to the site in the patient'"'"'s vasculature to be treated; and

a release wire removably threaded through the lumen of the pusher catheter member under said shoulder portions and over each of said plurality of helical windings to retain said plurality of helical windings on said notched portion of said pusher catheter member, said release wire being capable of being withdrawn from said notched portion of said pusher catheter member when the intravascular flow modifier and reinforcement device is positioned at the site in the patient'"'"'s vasculature to be treated to release and deploy the intravascular flow modifier and reinforcement device at the site in the patient'"'"'s vasculature to be treated.